Immuneering IMRX Balance Sheet (2020-2026)

NASDAQ IMRX
$3.76 +0.11 (+3.01%)
As of: Nov 10, 2026 · 1:20 PM EST
Reported Financials

Immuneering Quarterly Balance Sheet

Periods 26 quarters
Latest Sep 2026

Immuneering reported total assets of $182.56M and total liabilities of $13.88M for the quarter ended Sep 2026, down 24.3% year over year. This balance sheet covers 26 quarters of results from Jun 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
74.89M75.21M87.94M76.42M72.64M77.43M104.02M68.04M59.41M66.29M59.73M45.21M36.14M35.87M26.36M227.56M128.65M47.32M41.32M58.23M
Short-term InvestmentsInvestments (Current)
74.31M62.57M40.16M40.78M32.89M14.11M4.97M29.20M26.26M4.99M5.45M44.19M109.37M108.58M87.18M
Cash & Current Investments
149.20M137.77M128.10M117.20M105.52M91.54M108.99M97.24M85.67M71.28M59.73M50.66M36.14M35.87M26.36M227.56M172.83M156.69M149.90M145.41M
Receivables - NetNet Receivables
0.25M0.28M0.18M0.07M0.01M0.00M
Receivables
0.25M0.28M0.18M0.07M0.01M0.00M
Prepaid Assets
2.89M1.48M0.89M2.76M3.21M2.70M2.52M3.34M3.42M3.17M3.96M4.60M3.44M2.34M1.37M1.54M3.41M4.72M8.09M5.31M
Current Assets
152.33M139.53M129.17M120.02M108.75M94.23M111.51M100.58M89.08M74.45M63.69M55.26M39.59M38.21M27.73M229.10M176.25M161.41M157.99M150.71M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
0.81M0.87M0.99M1.31M1.37M1.33M1.37M1.39M1.40M1.35M1.29M1.21M1.12M1.05M0.96M0.89M0.94M0.94M0.88M0.81M
Long-Term Investments
1.00M44.18M41.95M32.77M20.71M
Goodwill
6.70M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M6.69M
Intangibles
0.44M0.43M0.42M0.42M0.41M0.40M0.39M0.39M0.38M0.37M0.37M0.36M0.35M0.34M0.34M0.33M0.32M0.31M0.31M0.30M
Goodwill & Intangibles
7.14M7.12M7.11M7.11M7.10M7.09M7.08M7.08M7.07M7.06M7.06M7.05M7.04M7.03M7.03M7.02M7.01M7.00M7.00M6.99M
Other Non-Current Assets
0.10M0.09M0.09M0.74M0.74M0.74M0.74M0.74M1.03M1.22M1.23M1.30M1.30M0.81M0.84M0.63M0.28M0.28M0.28M0.30M
Non-Current Assets
14.37M12.92M12.88M13.67M13.62M13.46M13.39M13.30M13.50M13.54M13.40M13.30M13.13M12.48M12.33M11.95M55.74M53.40M44.06M31.85M
Assets
166.70M152.45M142.05M133.69M122.37M107.70M124.90M113.88M102.58M87.98M77.09M68.56M52.71M50.68M40.06M241.06M231.99M214.81M202.06M182.56M
Liabilities
Current Liabilities
Accounts Payables
1.39M1.64M1.24M2.34M3.15M2.72M2.69M1.94M2.11M2.27M2.62M1.94M1.96M1.31M2.40M1.60M1.54M1.45M3.38M2.76M
Payables
1.39M1.64M1.24M2.34M3.15M2.72M2.69M1.94M2.11M2.27M2.62M1.94M1.96M1.31M2.40M1.60M1.54M1.45M3.38M2.76M
Accumulated Expenses
3.97M1.72M2.23M4.56M4.50M2.41M2.43M3.30M5.17M2.58M3.76M4.59M4.97M3.39M4.51M7.48M7.84M3.06M4.09M7.50M
Other Accumulated Expenses
0.05M0.05M0.04M0.02M0.03M0.03M0.08M0.26M0.02M0.09M0.06M0.23M0.06M0.21M0.08M0.29M0.04M0.21M0.09M
Total Current Liabilities
5.63M3.67M3.80M7.26M8.05M5.53M5.48M5.62M7.85M5.18M6.78M6.92M7.50M5.11M7.49M9.55M10.07M4.97M8.12M10.79M
Non-Current Liabilities
Preferred Stock Liabilities
Operating Leases
5.09M4.71M4.64M4.54M4.46M4.38M4.31M4.24M4.16M4.08M4.00M3.92M3.82M3.73M3.63M3.53M3.43M3.32M3.20M3.09M
Other Non-Current Liabilities
0.01M0.01M
Total Non-Current Liabilities
8.38M8.45M
Total Liabilities
10.72M8.39M8.46M11.80M12.52M9.91M9.79M9.86M12.01M9.26M10.78M10.84M11.33M8.84M11.12M13.08M13.50M8.29M11.32M13.88M
Shareholder's Equity
Common Equity
155.98M144.06M133.59M121.89M109.85M97.79M115.10M104.02M90.58M78.72M66.31M57.72M41.39M41.84M28.94M227.98M218.48M206.52M190.74M168.68M
Liabilities and Shareholders Equity
166.70M152.45M142.05M133.69M122.37M107.70M124.90M113.88M102.58M87.98M77.09M68.56M52.71M50.68M40.06M241.06M231.99M214.81M202.06M182.56M
Retained Earnings
-59.27M-72.17M-83.70M-96.54M-109.79M-123.39M-135.58M-148.18M-163.26M-177.57M-191.65M-206.24M-224.30M-239.34M-253.80M-268.74M-280.32M-293.80M-311.10M-335.24M

Immuneering Balance Sheet API

Pull Immuneering's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY